What is AMJB's health score?

JPMORGAN CHASE & CO (AMJB) has a TradeApes health score of 46 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is AMJB's estimated fair value?

Based on our 5-year discounted cash flow model, JPMORGAN CHASE & CO's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is AMJB undervalued or overvalued?

Our model currently rates AMJB as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for AMJB... Refresh in a moment for the full analysis.

JPMORGAN CHASE & CO (AMJB)

Financials Fair Value Medium mixed

Updated: 2026-04-21

TradeApes Score

hold

Financial Strength

35 Weak

Operating Trend

40 Weak

Relative Value

40 Weak

Capital Allocation

60 Healthy

Risk

80 Strong

Key Findings

+ Active buybacks — share count declining, capital returned to owners

Unlock Full Report →

− Large FCF burn — cash consumption exceeds 10% of revenue

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.